Peter Wolfe
CIK 1954398 · Chief Financial Officer · last filed 2025-07-15
Peter Wolfe is a Chief Financial Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ZVSA, was dated Jul 15, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVSA | Chief Financial Officer | — | $0.20 | — | $0 | 2 | 2025-07-15 |
| ZyVersa Therapeutics, Inc. (ZVSAW) Delisted | Chief Financial Officer | 44,585 | — | — | $0 | 2 | 2022-12-20 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-15 | ZVSA | Grant (A) | — | $0 | EDGAR |
| 2024-07-18 | ZVSA | Grant (A) | — | $0 | EDGAR |
| 2022-12-20 | ZyVersa Therapeutics, Inc. (ZVSAW) Delisted | Grant (A) | +3,000 | $8.6K | EDGAR |
| 2022-12-14 | ZyVersa Therapeutics, Inc. (ZVSAW) Delisted | Grant (A) | +41,585 | $0 | EDGAR |